Guest guest Posted December 21, 2010 Report Posted December 21, 2010 OncoPet Launches Cancer Detection Test for Dogs... OncoPet Diagnostics, a subsidiary of BioCurex Inc has launched a RECAF blood test designed to detect cancer in dogs. RECAF is a molecule that is present on cancer cells but not detected in significant levels on healthy cells or benign tumor cells. The RECAF cancer marker is not specific for any particular type of cancer, meaning the test can detect most types of common cancers, according to the company. OncoPet said the test is positive in about 90 percent of dogs afflicted with cancer and negative in 95 percent of healthy dogs. OncoPet Diagnostics will provide testing services in a similar manner to traditional laboratories . One notable distinction is that they will produce all the necessary reagents for the test and the testing service will be performed in-house at their BioCurex facilities. The company will pre-sell vouchers to distributors, each valid for one test. The distributor will sell the vouchers to veterinarians who will send the voucher and the sample to the OncoPet testing facility in Richmond, British Columbia, Canada,. Results are ready in about a week. The facility can process about 1,000 RECAF tests a day. The company hopes to some day adapt the test for cats. VetRed B.V. of the netherlands has signed a nonexclusive agreement to distribute the OncoPet RECAF test in Europe. Quote
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.